Petri T. Kovanen

41.3k total citations · 11 hit papers
453 papers, 26.0k citations indexed

About

Petri T. Kovanen is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Petri T. Kovanen has authored 453 papers receiving a total of 26.0k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Immunology, 174 papers in Surgery and 124 papers in Molecular Biology. Recurrent topics in Petri T. Kovanen's work include Mast cells and histamine (106 papers), Atherosclerosis and Cardiovascular Diseases (95 papers) and Lipoproteins and Cardiovascular Health (94 papers). Petri T. Kovanen is often cited by papers focused on Mast cells and histamine (106 papers), Atherosclerosis and Cardiovascular Diseases (95 papers) and Lipoproteins and Cardiovascular Health (94 papers). Petri T. Kovanen collaborates with scholars based in Finland, United States and Spain. Petri T. Kovanen's co-authors include Katariina Öörni, Michael S. Brown, Maija Kaartinen, Joseph L. Goldstein, Markku O. Pentikäinen, Ken A. Lindstedt, J L Goldstein, Antti Penttilä, Jorma Kokkonen and Kari K. Eklund and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Petri T. Kovanen

446 papers receiving 25.1k citations

Hit Papers

Lipoprotein(a) as a cardiova... 1979 2026 1994 2010 2010 2019 2011 2010 1981 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lipoprotein(a) as a cardiovascular risk factor: current status
    2010 1.3k citations Børge G. Nordestgaard, M. John Chapman et al. European Heart Journal profile →
  2. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
    2019 1.1k citations Magnus Bäck, Arif Yurdagul et al. Nature Reviews Cardiology profile →
  3. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
    2011 887 citations Henry N. Ginsberg, Pierre Amarenco et al. European Heart Journal profile →
  4. Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
    2010 776 citations Jani Lappalainen, Katariina Öörni et al. profile →
  5. Regulation of Plasma Cholesterol by Lipoprotein Receptors
    1981 743 citations Petri T. Kovanen et al. profile →
  6. Expression of Angiotensin II and Interleukin 6 in Human Coronary Atherosclerotic Plaques
    2000 532 citations Petri T. Kovanen et al. profile →
  7. Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol.
    1979 506 citations Petri T. Kovanen et al. profile →
  8. The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E.
    1980 408 citations Petri T. Kovanen et al. profile →
  9. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
    1981 366 citations Petri T. Kovanen et al. profile →
  10. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.
    1981 259 citations Petri T. Kovanen et al. Journal of Clinical Investigation profile →
  11. Receptor-Mediated Uptake of Lipoprotein-Cholesterol and Its Utilization for Steroid Synthesis in the Adrenal Cortex
    1979 257 citations Petri T. Kovanen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petri T. Kovanen Finland 77 8.8k 8.5k 7.5k 4.4k 4.3k 453 26.0k
Edward A. Fisher United States 98 9.8k 1.1× 9.3k 1.1× 11.6k 1.5× 4.8k 1.1× 5.2k 1.2× 433 35.2k
Jesús Egido Spain 91 5.1k 0.6× 6.4k 0.8× 10.6k 1.4× 3.0k 0.7× 5.6k 1.3× 621 31.6k
François Mach Switzerland 73 5.7k 0.7× 6.2k 0.7× 4.4k 0.6× 1.9k 0.4× 4.3k 1.0× 420 19.3k
James K. Liao United States 96 9.1k 1.0× 4.6k 0.5× 11.5k 1.5× 4.5k 1.0× 7.1k 1.6× 280 35.1k
Lina Badimón Spain 86 11.7k 1.3× 5.4k 0.6× 7.8k 1.0× 3.0k 0.7× 13.8k 3.2× 700 35.1k
Jan L. Breslow United States 96 12.0k 1.4× 4.2k 0.5× 9.7k 1.3× 8.7k 2.0× 4.9k 1.1× 266 29.9k
Seppo Ylä‐Herttuala Finland 109 9.0k 1.0× 8.3k 1.0× 21.8k 2.9× 1.8k 0.4× 4.2k 1.0× 748 44.5k
Alain Tedgui France 95 5.8k 0.7× 11.8k 1.4× 12.7k 1.7× 1.3k 0.3× 5.9k 1.4× 294 31.4k
Thomas M. McIntyre United States 89 3.7k 0.4× 5.8k 0.7× 10.1k 1.3× 1.8k 0.4× 2.3k 0.5× 240 26.2k
Stephen M. Prescott United States 89 4.8k 0.6× 6.1k 0.7× 9.1k 1.2× 1.4k 0.3× 2.0k 0.5× 233 25.6k

Countries citing papers authored by Petri T. Kovanen

Since Specialization
Citations

This map shows the geographic impact of Petri T. Kovanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petri T. Kovanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petri T. Kovanen more than expected).

Fields of papers citing papers by Petri T. Kovanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petri T. Kovanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petri T. Kovanen. The network helps show where Petri T. Kovanen may publish in the future.

Co-authorship network of co-authors of Petri T. Kovanen

This figure shows the co-authorship network connecting the top 25 collaborators of Petri T. Kovanen. A scholar is included among the top collaborators of Petri T. Kovanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petri T. Kovanen. Petri T. Kovanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Canyelles, Marina, Josefa Girona, Daiana Ibarretxe, et al.. (2024). PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia. JACC Basic to Translational Science. 9(10). 1195–1210. 1 indexed citations
2.
Vuorio, Alpo, Petri T. Kovanen, & Frederick J. Raal. (2023). Coronary microcirculatory dysfunction in hypercholesterolemic patients with COVID-19: potential benefit from cholesterol-lowering treatment. Annals of Medicine. 55(1). 2199218–2199218. 2 indexed citations
3.
Lorey, Martina B., Martin Hermansson, Julia M. Assini, et al.. (2023). Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages. Frontiers in Cardiovascular Medicine. 10. 1130162–1130162. 7 indexed citations
4.
Christensen, Jacob J., Ingunn Narverud, Maija Ruuth, et al.. (2021). Children with familial hypercholesterolemia display changes in LDL and HDL function: A cross‐sectional study. Journal of Internal Medicine. 290(5). 1083–1097. 8 indexed citations
5.
Vuorio, Alpo, Frederick J. Raal, Markku Kaste, & Petri T. Kovanen. (2021). Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment. Atherosclerosis. 320. 53–60. 20 indexed citations
6.
Tajbakhsh, Amir, et al.. (2020). Regulation of efferocytosis by caspase-dependent apoptotic cell death in atherosclerosis. The International Journal of Biochemistry & Cell Biology. 120. 105684–105684. 27 indexed citations
7.
Lee‐Rueckert, Miriam, Jani Lappalainen, Tommy Nordström, et al.. (2020). Acidic extracellular pH promotes accumulation of free cholesterol in human monocyte-derived macrophages via inhibition of ACAT1 activity. Atherosclerosis. 312. 1–7. 12 indexed citations
8.
Bäck, Magnus, Arif Yurdagul, Ira Tabas, Katariina Öörni, & Petri T. Kovanen. (2019). Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nature Reviews Cardiology. 16(7). 389–406. 1052 indexed citations breakdown →
9.
Tajbakhsh, Amir, et al.. (2019). Ca2+ Flux: Searching for a Role in Efferocytosis of Apoptotic Cells in Atherosclerosis. Journal of Clinical Medicine. 8(12). 2047–2047. 22 indexed citations
10.
Sahebkar, Amirhossein, Luis E. Simental‐Mendía, Petri T. Kovanen, et al.. (2017). Effects of orlistat on blood pressure: a systematic review and meta-analysis of 27 randomized controlled clinical trials. Journal of the American Society of Hypertension. 12(2). 80–96. 20 indexed citations
11.
Vaali, Kirsi, Jani Lappalainen, Mikko I. Mäyränpää, et al.. (2012). Imatinib mesylate alleviates diarrhea in a mouse model of intestinal allergy. Neurogastroenterology & Motility. 24(7). e325–35. 11 indexed citations
12.
Kankainen, Matti, Riina A. Kekkonen, Ken A. Lindstedt, et al.. (2011). Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cells. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 3 indexed citations
13.
Vapaatalo, Heikki, et al.. (2011). Downregulation of Bradykinin Type 2 Receptor Expression in Cardiac Endothelial Cells during Senescence. Journal of Vascular Research. 49(1). 13–23. 12 indexed citations
14.
Nordestgaard, Børge G., M. John Chapman, Kausik K. Ray, et al.. (2010). Lipoprotein(a) as a cardiovascular risk factor: current status. European Heart Journal. 31(23). 2844–2853. 1277 indexed citations breakdown →
15.
Helske, Satu, Tatu A. Miettinen, Helena Gylling, et al.. (2008). Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves. Journal of Lipid Research. 49(7). 1511–1518. 40 indexed citations
16.
Helske, Satu, Petri T. Kovanen, Ken A. Lindstedt, et al.. (2007). Increased Circulating Concentrations and Augmented Myocardial Extraction of Osteoprotegerin in Heart Failure Due to Left Ventricular Pressure Overload. European Journal of Heart Failure. 9(4). 357–363. 43 indexed citations
17.
Tuomainen, Anita M., Matti Jauhiainen, Petri T. Kovanen, et al.. (2007). Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice. Microbial Pathogenesis. 44(2). 111–117. 39 indexed citations
18.
Soininen, Pasi, Katariina Öörni, Hannu Maaheimo, et al.. (2007). 1H NMR at 800MHz facilitates detailed phospholipid follow-up during atherogenic modifications in low density lipoproteins. Biochemical and Biophysical Research Communications. 360(1). 290–294. 15 indexed citations
19.
Soinne, Lauri, Eija Saimanen, Petri T. Kovanen, et al.. (2005). Association of the Fibrinolytic System and Hemorheology with Symptoms in Patients with Carotid Occlusive Disease. Cerebrovascular Diseases. 20(3). 172–179. 11 indexed citations
20.
Koivisto, Ulla‐Maija, Hannu Turtola, Katriina Aalto‐Setälä, et al.. (1992). The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.. Journal of Clinical Investigation. 90(1). 219–228. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward A. Fisher Breakdown of academic impact, for papers by Jesús Egido Breakdown of academic impact, for papers by François Mach Breakdown of academic impact, for papers by James K. Liao Breakdown of academic impact, for papers by Lina Badimón Breakdown of academic impact, for papers by Jan L. Breslow Breakdown of academic impact, for papers by Seppo Ylä‐Herttuala Breakdown of academic impact, for papers by Alain Tedgui Breakdown of academic impact, for papers by Thomas M. McIntyre Breakdown of academic impact, for papers by Stephen M. Prescott
Rankless by CCL
2026